What is Pfizer's paxlovid and comirnaty — deferred revenues?

Pfizer (PFE) reported paxlovid and comirnaty — deferred revenues of $1.50B in Q1 2026.

What does paxlovid and comirnaty — deferred revenues mean?

Total payments received from customers for products that have not yet been delivered or fully earned.

Paxlovid and Comirnaty — Deferred revenues

Pfizer Paxlovid and Comirnaty — Deferred revenues remained flat by 0.0% to $1.50B in Q1 2026 compared to the prior quarter.

Analysis

StatementSegment

CategoryGrowth

SignalContext dependent

VolatilityVolatile

First reportedQ4 2025

Last reportedQ1 2026

Rolls up toContract with Customer, Liability

How to read this metric

An increase suggests strong future demand and advance commitments, while a decrease may indicate a slowdown in product uptake or the fulfillment of existing backlogs.

Detailed definition

This represents the total amount of consideration received from customers for which the performance obligations related...

Peer comparison

Similar to 'Unearned Revenue' or 'Contract Liabilities' found in other biopharmaceutical companies with large-scale government or commercial supply agreements.

Metric ID: pfe_segment_paxlovid_and_comirnaty_deferred_revenues

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$1.50B	$1.50B
QoQ Change	—	+0.0%

Range$1.50B – $1.50B

Similar Metrics at Other Companies

CienaCIEN View metric

Motorola Solutions, Inc.MSI View metric

AbbottABT View metric

Bloom EnergyBE View metric

Kinder MorganKMI View metric

Bloom EnergyBE View metric

Frequently Asked Questions

What is Pfizer's paxlovid and comirnaty — deferred revenues?: Pfizer (PFE) reported paxlovid and comirnaty — deferred revenues of $1.50B in Q1 2026.
What does paxlovid and comirnaty — deferred revenues mean?: Total payments received from customers for products that have not yet been delivered or fully earned.